- IBDEI3GL ; ; 19-NOV-2015
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,58182,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58182,1,3,0)
- ;;=3^Traumatic Glaucoma,Bilateral,Mild Stage
- ;;^UTILITY(U,$J,358.3,58182,1,4,0)
- ;;=4^H40.33X1
- ;;^UTILITY(U,$J,358.3,58182,2)
- ;;=^5005861
- ;;^UTILITY(U,$J,358.3,58183,0)
- ;;=H40.33X2^^272^2901^126
- ;;^UTILITY(U,$J,358.3,58183,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58183,1,3,0)
- ;;=3^Traumatic Glaucoma,Bilateral,Moderate Stage
- ;;^UTILITY(U,$J,358.3,58183,1,4,0)
- ;;=4^H40.33X2
- ;;^UTILITY(U,$J,358.3,58183,2)
- ;;=^5005862
- ;;^UTILITY(U,$J,358.3,58184,0)
- ;;=H40.33X3^^272^2901^127
- ;;^UTILITY(U,$J,358.3,58184,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58184,1,3,0)
- ;;=3^Traumatic Glaucoma,Bilateral,Severe Stage
- ;;^UTILITY(U,$J,358.3,58184,1,4,0)
- ;;=4^H40.33X3
- ;;^UTILITY(U,$J,358.3,58184,2)
- ;;=^5005863
- ;;^UTILITY(U,$J,358.3,58185,0)
- ;;=H40.33X4^^272^2901^124
- ;;^UTILITY(U,$J,358.3,58185,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58185,1,3,0)
- ;;=3^Traumatic Glaucoma,Bilateral,Indeterminate Stage
- ;;^UTILITY(U,$J,358.3,58185,1,4,0)
- ;;=4^H40.33X4
- ;;^UTILITY(U,$J,358.3,58185,2)
- ;;=^5005864
- ;;^UTILITY(U,$J,358.3,58186,0)
- ;;=H21.233^^272^2901^26
- ;;^UTILITY(U,$J,358.3,58186,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58186,1,3,0)
- ;;=3^Degeneration of Iris,Bilateral
- ;;^UTILITY(U,$J,358.3,58186,1,4,0)
- ;;=4^H21.233
- ;;^UTILITY(U,$J,358.3,58186,2)
- ;;=^5005189
- ;;^UTILITY(U,$J,358.3,58187,0)
- ;;=H40.61X1^^272^2901^40
- ;;^UTILITY(U,$J,358.3,58187,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58187,1,3,0)
- ;;=3^Drug-Induced Glaucoma,Right Eye,Mild Stage
- ;;^UTILITY(U,$J,358.3,58187,1,4,0)
- ;;=4^H40.61X1
- ;;^UTILITY(U,$J,358.3,58187,2)
- ;;=^5005907
- ;;^UTILITY(U,$J,358.3,58188,0)
- ;;=H40.013^^272^2901^59
- ;;^UTILITY(U,$J,358.3,58188,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58188,1,3,0)
- ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Bilateral
- ;;^UTILITY(U,$J,358.3,58188,1,4,0)
- ;;=4^H40.013
- ;;^UTILITY(U,$J,358.3,58188,2)
- ;;=^5005726
- ;;^UTILITY(U,$J,358.3,58189,0)
- ;;=H40.012^^272^2901^60
- ;;^UTILITY(U,$J,358.3,58189,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58189,1,3,0)
- ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Left Eye
- ;;^UTILITY(U,$J,358.3,58189,1,4,0)
- ;;=4^H40.012
- ;;^UTILITY(U,$J,358.3,58189,2)
- ;;=^5005725
- ;;^UTILITY(U,$J,358.3,58190,0)
- ;;=H40.011^^272^2901^61
- ;;^UTILITY(U,$J,358.3,58190,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58190,1,3,0)
- ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Right Eye
- ;;^UTILITY(U,$J,358.3,58190,1,4,0)
- ;;=4^H40.011
- ;;^UTILITY(U,$J,358.3,58190,2)
- ;;=^5005724
- ;;^UTILITY(U,$J,358.3,58191,0)
- ;;=H40.023^^272^2901^84
- ;;^UTILITY(U,$J,358.3,58191,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58191,1,3,0)
- ;;=3^Open-Angle w/ Borderline Findings,Hi Risk,Bilateral
- ;;^UTILITY(U,$J,358.3,58191,1,4,0)
- ;;=4^H40.023
- ;;^UTILITY(U,$J,358.3,58191,2)
- ;;=^5005730
- ;;^UTILITY(U,$J,358.3,58192,0)
- ;;=H40.063^^272^2901^108
- ;;^UTILITY(U,$J,358.3,58192,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58192,1,3,0)
- ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Bilateral
- ;;^UTILITY(U,$J,358.3,58192,1,4,0)
- ;;=4^H40.063
- ;;^UTILITY(U,$J,358.3,58192,2)
- ;;=^5005746
- ;;^UTILITY(U,$J,358.3,58193,0)
- ;;=H40.243^^272^2901^113
- ;;^UTILITY(U,$J,358.3,58193,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,58193,1,3,0)
- ;;=3^Residual Stage Angle-Closure Glaucoma,Bilateral
- ;;^UTILITY(U,$J,358.3,58193,1,4,0)
- ;;=4^H40.243
- ;;^UTILITY(U,$J,358.3,58193,2)
- ;;=^5005845
- ;;^UTILITY(U,$J,358.3,58194,0)
- ;;=H40.043^^272^2901^121
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GL 3952 printed Mar 13, 2025@21:53:13 Page 2
- IBDEI3GL ; ; 19-NOV-2015
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,58182,1,0)
- +2 ;;=^358.31IA^4^2
- +3 ;;^UTILITY(U,$J,358.3,58182,1,3,0)
- +4 ;;=3^Traumatic Glaucoma,Bilateral,Mild Stage
- +5 ;;^UTILITY(U,$J,358.3,58182,1,4,0)
- +6 ;;=4^H40.33X1
- +7 ;;^UTILITY(U,$J,358.3,58182,2)
- +8 ;;=^5005861
- +9 ;;^UTILITY(U,$J,358.3,58183,0)
- +10 ;;=H40.33X2^^272^2901^126
- +11 ;;^UTILITY(U,$J,358.3,58183,1,0)
- +12 ;;=^358.31IA^4^2
- +13 ;;^UTILITY(U,$J,358.3,58183,1,3,0)
- +14 ;;=3^Traumatic Glaucoma,Bilateral,Moderate Stage
- +15 ;;^UTILITY(U,$J,358.3,58183,1,4,0)
- +16 ;;=4^H40.33X2
- +17 ;;^UTILITY(U,$J,358.3,58183,2)
- +18 ;;=^5005862
- +19 ;;^UTILITY(U,$J,358.3,58184,0)
- +20 ;;=H40.33X3^^272^2901^127
- +21 ;;^UTILITY(U,$J,358.3,58184,1,0)
- +22 ;;=^358.31IA^4^2
- +23 ;;^UTILITY(U,$J,358.3,58184,1,3,0)
- +24 ;;=3^Traumatic Glaucoma,Bilateral,Severe Stage
- +25 ;;^UTILITY(U,$J,358.3,58184,1,4,0)
- +26 ;;=4^H40.33X3
- +27 ;;^UTILITY(U,$J,358.3,58184,2)
- +28 ;;=^5005863
- +29 ;;^UTILITY(U,$J,358.3,58185,0)
- +30 ;;=H40.33X4^^272^2901^124
- +31 ;;^UTILITY(U,$J,358.3,58185,1,0)
- +32 ;;=^358.31IA^4^2
- +33 ;;^UTILITY(U,$J,358.3,58185,1,3,0)
- +34 ;;=3^Traumatic Glaucoma,Bilateral,Indeterminate Stage
- +35 ;;^UTILITY(U,$J,358.3,58185,1,4,0)
- +36 ;;=4^H40.33X4
- +37 ;;^UTILITY(U,$J,358.3,58185,2)
- +38 ;;=^5005864
- +39 ;;^UTILITY(U,$J,358.3,58186,0)
- +40 ;;=H21.233^^272^2901^26
- +41 ;;^UTILITY(U,$J,358.3,58186,1,0)
- +42 ;;=^358.31IA^4^2
- +43 ;;^UTILITY(U,$J,358.3,58186,1,3,0)
- +44 ;;=3^Degeneration of Iris,Bilateral
- +45 ;;^UTILITY(U,$J,358.3,58186,1,4,0)
- +46 ;;=4^H21.233
- +47 ;;^UTILITY(U,$J,358.3,58186,2)
- +48 ;;=^5005189
- +49 ;;^UTILITY(U,$J,358.3,58187,0)
- +50 ;;=H40.61X1^^272^2901^40
- +51 ;;^UTILITY(U,$J,358.3,58187,1,0)
- +52 ;;=^358.31IA^4^2
- +53 ;;^UTILITY(U,$J,358.3,58187,1,3,0)
- +54 ;;=3^Drug-Induced Glaucoma,Right Eye,Mild Stage
- +55 ;;^UTILITY(U,$J,358.3,58187,1,4,0)
- +56 ;;=4^H40.61X1
- +57 ;;^UTILITY(U,$J,358.3,58187,2)
- +58 ;;=^5005907
- +59 ;;^UTILITY(U,$J,358.3,58188,0)
- +60 ;;=H40.013^^272^2901^59
- +61 ;;^UTILITY(U,$J,358.3,58188,1,0)
- +62 ;;=^358.31IA^4^2
- +63 ;;^UTILITY(U,$J,358.3,58188,1,3,0)
- +64 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Bilateral
- +65 ;;^UTILITY(U,$J,358.3,58188,1,4,0)
- +66 ;;=4^H40.013
- +67 ;;^UTILITY(U,$J,358.3,58188,2)
- +68 ;;=^5005726
- +69 ;;^UTILITY(U,$J,358.3,58189,0)
- +70 ;;=H40.012^^272^2901^60
- +71 ;;^UTILITY(U,$J,358.3,58189,1,0)
- +72 ;;=^358.31IA^4^2
- +73 ;;^UTILITY(U,$J,358.3,58189,1,3,0)
- +74 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Left Eye
- +75 ;;^UTILITY(U,$J,358.3,58189,1,4,0)
- +76 ;;=4^H40.012
- +77 ;;^UTILITY(U,$J,358.3,58189,2)
- +78 ;;=^5005725
- +79 ;;^UTILITY(U,$J,358.3,58190,0)
- +80 ;;=H40.011^^272^2901^61
- +81 ;;^UTILITY(U,$J,358.3,58190,1,0)
- +82 ;;=^358.31IA^4^2
- +83 ;;^UTILITY(U,$J,358.3,58190,1,3,0)
- +84 ;;=3^Glaucoma Suspect/Open Angle w/ Borderline Findings,Low Risk,Right Eye
- +85 ;;^UTILITY(U,$J,358.3,58190,1,4,0)
- +86 ;;=4^H40.011
- +87 ;;^UTILITY(U,$J,358.3,58190,2)
- +88 ;;=^5005724
- +89 ;;^UTILITY(U,$J,358.3,58191,0)
- +90 ;;=H40.023^^272^2901^84
- +91 ;;^UTILITY(U,$J,358.3,58191,1,0)
- +92 ;;=^358.31IA^4^2
- +93 ;;^UTILITY(U,$J,358.3,58191,1,3,0)
- +94 ;;=3^Open-Angle w/ Borderline Findings,Hi Risk,Bilateral
- +95 ;;^UTILITY(U,$J,358.3,58191,1,4,0)
- +96 ;;=4^H40.023
- +97 ;;^UTILITY(U,$J,358.3,58191,2)
- +98 ;;=^5005730
- +99 ;;^UTILITY(U,$J,358.3,58192,0)
- +100 ;;=H40.063^^272^2901^108
- +101 ;;^UTILITY(U,$J,358.3,58192,1,0)
- +102 ;;=^358.31IA^4^2
- +103 ;;^UTILITY(U,$J,358.3,58192,1,3,0)
- +104 ;;=3^Primary Angle-Closure w/o Glaucoma Damage,Bilateral
- +105 ;;^UTILITY(U,$J,358.3,58192,1,4,0)
- +106 ;;=4^H40.063
- +107 ;;^UTILITY(U,$J,358.3,58192,2)
- +108 ;;=^5005746
- +109 ;;^UTILITY(U,$J,358.3,58193,0)
- +110 ;;=H40.243^^272^2901^113
- +111 ;;^UTILITY(U,$J,358.3,58193,1,0)
- +112 ;;=^358.31IA^4^2
- +113 ;;^UTILITY(U,$J,358.3,58193,1,3,0)
- +114 ;;=3^Residual Stage Angle-Closure Glaucoma,Bilateral
- +115 ;;^UTILITY(U,$J,358.3,58193,1,4,0)
- +116 ;;=4^H40.243
- +117 ;;^UTILITY(U,$J,358.3,58193,2)
- +118 ;;=^5005845
- +119 ;;^UTILITY(U,$J,358.3,58194,0)
- +120 ;;=H40.043^^272^2901^121
